Medtronic PLC
NYSE:MDT
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
76.84
92.27
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Medtronic PLC
Medtronic PLC
Research & Development
Medtronic PLC
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medtronic PLC
NYSE:MDT
|
Research & Development
-$2.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
|
Trinity Biotech PLC
NASDAQ:TRIB
|
Research & Development
-$4.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-1%
|
|
|
STERIS plc
NYSE:STE
|
Research & Development
-$103.7m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-8%
|
|
Medtronic PLC
Glance View
Medtronic PLC, a powerhouse in the global medical technology sector, was established in 1949 and has since evolved into a key player in advancing healthcare through innovative solutions. Headquartered in Dublin, Ireland, Medtronic operates across numerous medical areas, including cardiovascular, diabetes, neurological, and surgical technologies. Their commitment to improving patient outcomes is evident in their diverse product portfolio, which includes groundbreaking devices such as insulin pumps, heart valves, and spinal implants. With a presence in over 150 countries and a robust supply chain, Medtronic is strategically positioned to address the increasing demand for healthcare solutions driven by an aging population and the growing prevalence of chronic diseases. For investors, Medtronic represents a compelling opportunity backed by strong financial fundamentals and a commitment to continuous innovation. The company has demonstrated consistent revenue growth and profitability, driven by investments in research and development that align with emerging healthcare trends. Their focus on strategic acquisitions and partnerships enhances their competitive edge, enabling them to expand into new markets and technologies. Furthermore, Medtronic's commitment to sustainability and corporate responsibility resonates with today’s socially-conscious investors. As healthcare evolves, Medtronic stands poised to lead the charge in transforming patient care, making it a worthy consideration for those looking to invest in the future of medical technology.
See Also
What is Medtronic PLC's Research & Development?
Research & Development
-2.7B
USD
Based on the financial report for Jul 26, 2024, Medtronic PLC's Research & Development amounts to -2.7B USD.
What is Medtronic PLC's Research & Development growth rate?
Research & Development CAGR 10Y
-6%
Over the last year, the Research & Development growth was -3%. The average annual Research & Development growth rates for Medtronic PLC have been -2% over the past three years , -3% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
